Daniel Gold MD
@DanielGold_MD
Followers
25
Following
9
Media
0
Statuses
7
Cardiology Fellow, Clinical Investigator Track @Emory_Heart. Aspiring CHIP Interventional Cardiologist
Joined October 2023
Part 1: High 5 @emoryheart authors: @DanielGold_MD @PSandesara_MD @vardhmaan_jain M. Gold, N. Vatsa, SR Desai, @MalikaElhHassan, K. Ejaz, Z. Alvi, A. Alkhoder, A. Rahbar, @CardioOnc C. Varounis, @wissamj123 @wjn_md AA Quyyumi. https://t.co/mkPxVabYOR
pubmed.ncbi.nlm.nih.gov
NT pro-BNP levels can help identify individuals who may benefit from CTO revascularization.
1
1
0
Kudos @emoryheart @EmoryRollins @EmoryDeptofMed @EmoryMedicine authors & @DanielGold_MD @PSandesara_MD @vardhmaan_jain @akyadalam @AlexRazavi @MalikaElhHassan @ekwaller @wissamj123 @wjn_md for "Circulating Progenitor Cells..." @emoryhealthsci
https://t.co/RcL7MmhoQa
pubmed.ncbi.nlm.nih.gov
Individuals with higher CPC counts have greater collateral development and lower ischemic burden in the presence of a CTO.
0
2
4
Dr. Daniel Gold, cardiology fellow, presenting his research a #GAACC23 Congratulations on winning the Nanette Kass Wenger Award for Excellence in Research and Scholarship! @NanetteWenger @emoryhealthcare @gina_lundberg
0
4
10
Baseline hsTn-I levels may help identify those most likely to experience a survival benefit from CTO revascularization. #AHAJournals @DanielGold_MD @emory_heart
https://t.co/zfp7d7dMkU
0
3
3
Dr. Daniel Gold, MD from @EmoryUniversity presenting Prognostic Significance of High-sensitivity Troponin I and N Terminal Pro-brain Natriuretic Peptide Levels in Patients with Coronary Chronic Total Occlusion. #MedTwitter #MedX #MedEd #NCYIF23
0
3
12